Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Filings indexed 1,188 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-19 English
10-Q - AtriCure, Inc. (0001323885) (Filer)
Interim / Quarterly Report
2026-05-06 English
8-K - AtriCure, Inc. (0001323885) (Filer)
Regulatory Filings
2026-05-05 English
DEF 14A - AtriCure, Inc. (0001323885) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English
4 - ATRICURE, INC. (0001323885) (Filer)
Director's Dealing
2026-03-03 English
4 - ATRICURE, INC. (0001323885) (Filer)
Director's Dealing
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.